Literature DB >> 19598206

A review of current applications of mass spectrometry for neuroproteomics in epilepsy.

Xinyu Liu1, Fuqiang Wen, Jinliang Yang, Lijuan Chen, Yu-Quan Wei.   

Abstract

The brain is unquestionably the most fascinating organ, and the hippocampus is crucial in memory storage and retrieval and plays an important role in stress response. In temporal lobe epilepsy (TLE), the seizure origin typically involves the hippocampal formation. Despite tremendous progress, current knowledge falls short of being able to explain its function. An emerging approach toward an improved understanding of the complex molecular mechanisms that underlie functions of the brain and hippocampus is neuroproteomics. Mass spectrometry has been widely used to analyze biological samples, and has evolved into an indispensable tool for proteomics research. In this review, we present a general overview of the application of mass spectrometry in proteomics, summarize neuroproteomics and systems biology-based discovery of protein biomarkers for epilepsy, discuss the methodology needed to explore the epileptic hippocampus proteome, and also focus on applications of ingenuity pathway analysis (IPA) in disease research. This neuroproteomics survey presents a framework for large-scale protein research in epilepsy that can be applied for immediate epileptic biomarker discovery and the far-reaching systems biology understanding of the protein regulatory networks. Ultimately, knowledge attained through neuroproteomics could lead to clinical diagnostics and therapeutics to lessen the burden of epilepsy on society. Copyright 2009 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 19598206     DOI: 10.1002/mas.20243

Source DB:  PubMed          Journal:  Mass Spectrom Rev        ISSN: 0277-7037            Impact factor:   10.946


  5 in total

1.  Single Cell Immuno-Laser Microdissection Coupled to Label-Free Proteomics to Reveal the Proteotypes of Human Brain Cells After Ischemia.

Authors:  Teresa García-Berrocoso; Víctor Llombart; Laura Colàs-Campàs; Alexandre Hainard; Virginie Licker; Anna Penalba; Laura Ramiro; Alba Simats; Alejandro Bustamante; Elena Martínez-Saez; Francesc Canals; Jean-Charles Sanchez; Joan Montaner
Journal:  Mol Cell Proteomics       Date:  2017-11-13       Impact factor: 5.911

2.  Serum Prolidase Enzyme Activity Level: Not a Predictive Biomarker for Epilepsy.

Authors:  Zeynep Ozozen Ayas; Dilcan Kotan; Mehmet Akdogan; Mustafa Ercan Gunel
Journal:  Eurasian J Med       Date:  2018-11-30

3.  Hippocampal Proteome of Rats Subjected to the Li-Pilocarpine Epilepsy Model and the Effect of Carisbamate Treatment.

Authors:  José Eduardo Marques-Carneiro; Daniele Suzete Persike; Julia Julie Litzahn; Jean-Christophe Cassel; Astrid Nehlig; Maria José da Silva Fernandes
Journal:  Pharmaceuticals (Basel)       Date:  2017-07-30

4.  Proteomic analysis of human epileptic neocortex predicts vascular and glial changes in epileptic regions.

Authors:  Gal Keren-Aviram; Fabien Dachet; Shruti Bagla; Karina Balan; Jeffrey A Loeb; Edward A Dratz
Journal:  PLoS One       Date:  2018-04-10       Impact factor: 3.240

5.  Association between different levels of lipid metabolism‑related enzymes and fatty acid synthase in Wilms' tumor.

Authors:  Xiaoqing Wang; Guoqiang Du; Yidi Wu; Yongfei Zhang; Feng Guo; Wei Liu; Rongde Wu
Journal:  Int J Oncol       Date:  2019-12-20       Impact factor: 5.650

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.